Edition:
United States

Revance Therapeutics Inc (RVNC.OQ)

RVNC.OQ on NASDAQ Stock Exchange Global Market

32.15USD
14 Dec 2017
Change (% chg)

-- (--)
Prev Close
$32.15
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
82,381
52-wk High
$37.20
52-wk Low
$15.95

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Angus Russell

61 2014 Independent Chairman of the Board

L. Daniel Browne

55 Co-Founder, President, Chief Executive Officer, Director

Lauren Silvernail

58 2015 Chief Financial Officer, Chief Business Officer

Abhay Joshi

54 2015 Chief Operating Officer

Todd Zavodnick

45 2017 Chief Commercial Officer and President, Aesthetics & Therapeutics